Wick Capital Partners, LLC Astrazeneca PLC Transaction History
Wick Capital Partners, LLC
- $312 Million
- Q1 2025
A detailed history of Wick Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wick Capital Partners, LLC holds 7,285 shares of AZN stock, worth $513,883. This represents 0.17% of its overall portfolio holdings.
Number of Shares
7,285
Previous 7,972
8.62%
Holding current value
$513,883
Previous $522,000
2.49%
% of portfolio
0.17%
Previous 0.17%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.03 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...